Disialoganglioside GD2 Expression in Pediatric Rhabdomyosarcoma
2019
Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. Despite aggressive therapy, patients with metastatic or relapsed disease experience dismal outcomes and novel therapies are urgently needed. In this study, we evaluated expression of disialoganglioside (GD2), a cell surface ant
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI